{{Rsnum
|rsid=3134883
|Gene=IL2RA
|Chromosome=10
|position=6100725
|Orientation=minus
|GMAF=0.2149
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 46.8 | 44.1 | 9.0
| HCB | 45.5 | 43.3 | 11.2
| JPT | 58.4 | 35.4 | 6.2
| YRI | 93.2 | 6.8 | 0.0
| ASW | 86.0 | 14.0 | 0.0
| CHB | 45.5 | 43.3 | 11.2
| CHD | 52.8 | 43.5 | 3.7
| GIH | 50.5 | 41.6 | 7.9
| LWK | 95.4 | 4.6 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 85.9 | 12.8 | 1.3
| TSI | 59.4 | 38.6 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19956099
|Title=The type I diabetes association of the IL2RA locus
|OA=1
}}

{{PMID Auto
|PMID=19956101
|Title=Overview of the Rapid Response data.
|OA=1
}}

{{PMID Auto
|PMID=22951725
|Title=Association analyses identify three susceptibility Loci for vitiligo in the Chinese Han population.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}